WHAT IS NPC GOLDTM

 

NPC GOLDTM is a quantitative Epstein-Barr Virus (EBV) DNA test that informs you of the EBV viral load with a draw of blood. Our test is highly sensitive because we target the BamHI-W CpG Islands specifically within the EBV virus. This makes our test useful for the screening of nasopharyngeal cancer in the early stages, even when there are no symptoms.

 WHAT IS NPC GOLDTM

NPC GOLDTM is a quantitative Epstein-Barr Virus (EBV) DNA test that informs you of the EBV viral load with a draw of blood. Our test is highly sensitive because we target the BamHI-W CpG Islands specifically within the EBV virus. This makes our test useful for the screening of nasopharyngeal cancer in the early stages, even when there are no symptoms.

INTERNATIONAL QUALITY ASSURED

The technology behind NPC GOLDTM has been assessed by international quality assurance agencies and achieved top-level test results. Read more about the results here.  

QCMD-results-blurred

INTERNATIONAL QUALITY ASSURED

The technology behind NPC GOLDTM has been assessed by international quality assurance agencies and achieved top-level test results. Read more about the results here.  

QCMD-results-blurred

RELEVANT PUBLICATIONS

Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

Circulating cell-free Epstein–Barr virus (EBV) DNA is a biomarker for nasopharyngeal carcinoma. The research team conducted a prospective study to investigate whether EBV DNA in plasma samples would be useful to screen for early nasopharyngeal carcinoma in asymptomatic persons.

View Publication

Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy

We investigate here the utility of various circulating biomarkers in NPC, with a special interest in the performance of CTC enumeration as a novel biomarker against more conventional EBV cfDNA quantitation using qPCR and digital PCR (dPCR) with EBNA1 and BamHI-W as targets.

View Publication

RELEVANT PUBLICATIONS

Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy

We investigate here the utility of various circulating biomarkers in NPC, with a special interest in the performance of CTC enumeration as a novel biomarker against more conventional EBV cfDNA quantitation using qPCR and digital PCR (dPCR) with EBNA1 and BamHI-W as targets.

View Publication

Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

Circulating cell-free Epstein–Barr virus (EBV) DNA is a biomarker for nasopharyngeal carcinoma. The research team conducted a prospective study to investigate whether EBV DNA in plasma samples would be useful to screen for early nasopharyngeal carcinoma in asymptomatic persons.

View Publication

NOW AVAILABLE

 

NPC GOLDTM can screen for nasopharyngeal cancer in patients with no symptoms of the disease and monitor their post-radiotherapy conditions with just a single draw of blood. Request for a kit now.  

NOW AVAILABLE

 

NPC GOLDTM can screen for nasopharyngeal cancer in patients with no symptoms of the disease and monitor their post-radiotherapy conditions with just a single draw of blood. Request for a kit now.  

ORDERING NPC GOLDTM

If you are a practicing doctor in Singapore, you can order the tests with us online or call our sales hotline (+65 6592 5102). If you would like to find out more, we can schedule an appointment with you to explain our somatic and germline cancers tests in person. 

ORDERING NPC GOLDTM

If you are a practicing doctor in Singapore, you can order the tests with us online or call our sales hotline (+65 6592 5102). If you would like to find out more, we can schedule an appointment with you to explain our somatic and germline cancers tests in person.